US Contraceptive Market

US Contraceptive Market

The U.S. contraceptives market was valued at USD 7 billion in 2023 and is projected to grow at a CAGR of 7.2% between 2024 and 2032. Contraceptives, also known as birth control, include a variety of methods, both devices and drugs, that help prevent pregnancy by reducing the likelihood of conception. The market covers numerous contraceptive options, such as condoms, IUDs, pills, and vaginal rings.

A significant trend shaping the market is the rising preference for long-acting reversible contraceptives (LARCs), including intrauterine devices (IUDs) and implants. While hormonal contraceptives, like oral pills, continue to be widely used, newer options, such as non-hormonal gels, are gaining popularity, offering alternatives for those who prefer non-hormonal methods.

By product type, the market is divided into drugs and devices. In 2023, the drugs segment led the market, generating around USD 3.8 billion in revenue. Contraceptive drugs are highly effective when used correctly, providing individuals with a reliable means of controlling their reproductive health. The ease of use of options like oral pills and patches allows users to manage contraception without medical intervention, supporting flexibility and autonomy in family planning.

The distribution channel of contraceptives in the U.S. is categorized into retail pharmacies, hospital pharmacies, online platforms, and other channels. Retail pharmacies held the largest market share, accounting for 45.9% in 2023. Their accessibility makes them a convenient option for many individuals, as no appointment is needed to purchase contraceptives. Retail pharmacies also offer both prescription and over-the-counter contraceptive products, making a wide variety of options readily available to consumers, whether or not they have a prescription.

In the East South Central region, the contraceptives market reached USD 1.7 billion in 2023 and is expected to grow at a CAGR of 7.9% through 2032. High rates of unintended pregnancies and growing awareness of family planning are driving the demand for contraceptives in this region. Government initiatives and public health campaigns have been instrumental in expanding access to contraception. Additionally, the increased adoption of long-acting reversible contraceptives (LARCs) like IUDs and implants is further contributing to market growth in the region.